Prediction of magnetic resonance imaging scoring system for differentiating leiomyomas from leiomyosarcomas: A cross-sectional study

Read full text Summarise with VIRAT
Authors: Onur Yavuz, Bahadır Saatli, Kadir Alper Mankan, Canan Altay, Aslı Akdöner
Cited by: 0
References: 1

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objectives The aim of the study was to evaluate the preoperative magnetic resonance imaging (MRI) features that best distinguish leiomyomas (UM) from leiomyosarcomas (LMS) and to predict UMs preoperatively using an MRI scoring system. Methods This was a cross-sectional study conducted at a tertiary center. Between 2013 and 2023, 109 patients who underwent myomectomy or hysterectomy with pelvic MRI in the six months before the operation and had a histopathologically confirmed report of UM or LMS were included in the study. The cases were classified as Group 1 (UM; n=101, 92.6%) and Group 2 (LMS; n=8, 7.4%) according to histopathology reports. Non-normally distributed variables were analyzed using the Mann-Whitney U test. Categorical data were analyzed using the Chi-square test and Fisher's exact test. Receiver Operating Characteristic (ROC) analysis was performed to calculate the cut-off value, specificity and sensitivity of MRI scoring system. Logistic regression analysis were used to evaluate MRI features. The p value considered statistically significant was

Fields of Study & Subjects

Uterine Myomas and Treatments MRI in cancer diagnosis Sarcoma Diagnosis and Treatment

Publication details

Journal / source
Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi
Volume
23
Issue
1
Pages
87–93
Publication date
31 March 2026
Language
TR